These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 5274461)

  • 1. Heme biosynthesis in intermittent acute prophyria: decreased hepatic conversion of porphobilinogen to porphyrins and increased delta aminolevulinic acid synthetase activity.
    Strand LJ; Felsher BF; Redeker AG; Marver HS
    Proc Natl Acad Sci U S A; 1970 Nov; 67(3):1315-20. PubMed ID: 5274461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble hepatic delta-aminolevulinic acid synthetase: end-product inhibition of the partially purified enzyme.
    Sholnick PL; Hammaker LE; Marver HS
    Proc Natl Acad Sci U S A; 1969 May; 63(1):65-70. PubMed ID: 5257968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute intermittent porphyria: studies of the enzymatic basis of disordered haem biosynthesis.
    Strand LJ; Manning J; Marver HS
    S Afr Med J; 1971 Sep; ():108-11. PubMed ID: 5150262
    [No Abstract]   [Full Text] [Related]  

  • 4. Biochemical defects in two types of human hepatic porphyria.
    Kaufman L; Marver HS
    N Engl J Med; 1970 Oct; 283(18):954-8. PubMed ID: 5470255
    [No Abstract]   [Full Text] [Related]  

  • 5. [Porphyrins and the activity of some enzymes taking part in the biosynthesis of heme in tissues of a deceased patient with acute intermittent porphyria].
    Gutniak O; Koziolowa H; Panfil B; Dancewicz AM
    Acta Haematol Pol; 1972; 3(1):35-43. PubMed ID: 4650111
    [No Abstract]   [Full Text] [Related]  

  • 6. Acute intermittent porphyria. Increased ALA-synthetase activity during an acute attack.
    Sweeney VP; Pathak MA; Asbury AK
    Brain; 1970; 93(2):369-80. PubMed ID: 5422412
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies in porphyria. VI. Biosynthesis of porphyrins in mammalian skin and in the skin of porphyric patients.
    Bickers DR; Keogh L; Rifkind AB; Harber LC; Kappas A
    J Invest Dermatol; 1977 Jan; 68(1):5-9. PubMed ID: 830770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic delta-aminolaevulinic acid synthetase activity in symptomatic porphyria.
    Zail SS; Joubert SM
    Br J Haematol; 1968 Aug; 15(2):123-9. PubMed ID: 5675527
    [No Abstract]   [Full Text] [Related]  

  • 9. Intermittent acute porphyria: the enzymatic defect.
    Meyer UA; Schmid R
    Res Publ Assoc Res Nerv Ment Dis; 1974; 53():211-24. PubMed ID: 4280105
    [No Abstract]   [Full Text] [Related]  

  • 10. [STUDIES OF THE ACTIVITY OF DELTA-AMINOLEVULINIC ACID SYNTHETASE IN THE MITOCHONDRIA OF LIVER CELLS OF THE RABBIT AND WHITE RAT POISONED WITH LEAD ACETATE].
    GAJDOS A; GAJDOS-TOEROEK M
    Rev Fr Etud Clin Biol; 1964; 9():629-32. PubMed ID: 14187798
    [No Abstract]   [Full Text] [Related]  

  • 11. The induction of -aminolevulinic acid synthetase in cultured liver cells. The effects of end product and inhibitors of heme synthesis.
    Strand LJ; Manning J; Marver HS
    J Biol Chem; 1972 May; 247(9):2820-7. PubMed ID: 5025100
    [No Abstract]   [Full Text] [Related]  

  • 12. Decreased red cell uroporphyrinogen I synthetase activity in intermittent acute porphyria.
    Strand LJ; Meyer UA; Felsher BF; Redeker AG; Marver HS
    J Clin Invest; 1972 Oct; 51(10):2530-6. PubMed ID: 5056653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of DL-propranolol on delta-aminolevulinic acid synthetase activity and urinary excretion of porphyrins in allylisopropylacetamide-induced experimental porphyria.
    Blum I; Schoenfeld N; Atsmon A
    Biochim Biophys Acta; 1973 Sep; 320(2):242-8. PubMed ID: 4750745
    [No Abstract]   [Full Text] [Related]  

  • 14. Alterations in the activity of enzymes of haem biosynthesis in lead poisoning and acute hepatic prophyria.
    Campbell BC; Brodie MJ; Thompson GG; Meredith PA; Moore MR; Goldberg A
    Clin Sci Mol Med; 1977 Oct; 53(4):335-40. PubMed ID: 913057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenesis and clinical features of the acute hepatic porphyrias (AHPs).
    Bonkovsky HL; Dixon N; Rudnick S
    Mol Genet Metab; 2019 Nov; 128(3):213-218. PubMed ID: 30987916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delta-aminolevulinic acid synthetase activity in erythroblasts of patients with sideroblastic anemia.
    Takaku F; Nakao K
    Life Sci II; 1971 Jul; 10(13):721-6. PubMed ID: 5561051
    [No Abstract]   [Full Text] [Related]  

  • 17. Semimicroassay method for hepatic delta-aminolevulinic acid synthetase activity.
    Levere RD; Gitin EL; Sassa S
    J Lab Clin Med; 1970 Jan; 75(1):137-44. PubMed ID: 5410493
    [No Abstract]   [Full Text] [Related]  

  • 18. Delta-aminolaevulinic acid synthetase activity in normal and porphyric human livers.
    Dowdle EB; Mustard P; Eales L
    S Afr Med J; 1967 Nov; 41(42):1093-6. PubMed ID: 6061512
    [No Abstract]   [Full Text] [Related]  

  • 19. Detection of delta-aminolevulinic acid, porphobilinogen and porphyrins related to heme biosynthesis by high-performance liquid chromatography.
    Ho J; Guthrie R; Tieckelmann H
    J Chromatogr; 1986 Feb; 375(1):57-63. PubMed ID: 3958110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intermittent acute porphyria. Clinical and biochemical studies of disordered heme biosynthesis.
    Meyer UA
    Enzyme; 1973; 16(1):334-42. PubMed ID: 4791052
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.